Skip Nav Destination
Abstract CT128: Palbociclib in combination with fulvestrant or tamoxifen as treatment for hormone receptor positive metastatic breast cancer with prior chemotherapy for advanced disease (TBCRC 035): A Phase II study with pharmacodynamic markers
Cancer Res (2019) 79 (13_Supplement): CT128.
This article has been cited by the following articles in journals that are participating in CrossRef Cited-by Linking.
- Komal Jhaveri
- Howard A Burris 3rd
- Timothy A Yap
- Erika Hamilton
- Hope S Rugo
- Jonathan W Goldman
- Stephen Dann
- Feng Liu
- Gilbert Y Wong
- Heike Krupka
- Geoffrey I Shapiro
Expert Review of Anticancer Therapy (2021) 21 (10): 1105.
